92 results
8-K
EX-10.3
v9bhdtt
11 Mar 24
Dyadic Announces Closing of Private Placement of
8:45am
8-K
EX-10.1
6ow8rw05b c12z
11 Mar 24
Dyadic Announces Closing of Private Placement of
8:45am
8-K
EX-10.1
h53adit h8tt
12 Apr 23
Dyadic Announces Expanded Licensing Agreement to Develop and Commercialize Vaccines and Biologics for African Continent
8:30am
8-K
EX-10.1
lbw9 dpvadw6qst
11 May 22
Dyadic Announces Research, License and Collaboration for the Manufacture of
9:57am
8-K
EX-10.1
txfxbxckx3ucuhkf7j
17 Dec 21
Dyadic Announces Research, License and Collaboration Agreement with Janssen
7:10am
8-K
EX-10.1
ngo0lbcb osqrl19
9 Nov 21
Dyadic Appoints Chief Business Officer to Executive Leadership Team
8:40am
8-K
EX-99.1
viy0j6ag
9 Nov 21
Dyadic Appoints Chief Business Officer to Executive Leadership Team
8:40am